Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.84 USD | -1.18% | +1.69% | -40.85% |
Mar. 19 | Tranche Update on Zepp Health Corporation's Equity Buyback Plan announced on November 16, 2021. | CI |
Mar. 19 | Transcript : Zepp Health Corporation, Q4 2023 Earnings Call, Mar 18, 2024 |
Sales 2023 | 2.5B 345M | Sales 2024 * | 2.3B 318M | Capitalization | 376M 51.93M |
---|---|---|---|---|---|
Net income 2023 | -212M -29.29M | Net income 2024 * | -131M -18.1M | EV / Sales 2023 | 0.25 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.16 x |
P/E ratio 2023 |
-2.93
x | P/E ratio 2024 * |
-11.3
x | Employees | 987 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 33.95% |
Latest transcript on Zepp Health Corporation
1 day | -1.18% | ||
1 week | +1.69% | ||
Current month | -17.65% | ||
1 month | -8.00% | ||
3 months | -40.00% | ||
6 months | -18.45% | ||
Current year | -40.85% |
Managers | Title | Age | Since |
---|---|---|---|
Wang Huang
CEO | Chief Executive Officer | 48 | 13-12-26 |
Leon Cheng Deng
DFI | Director of Finance/CFO | 41 | 20-09-30 |
Mei Hui Fan
CTO | Chief Tech/Sci/R&D Officer | 45 | 21-08-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bing Xie
BRD | Director/Board Member | 57 | 20-11-21 |
Hong Jiang Zhang
BRD | Director/Board Member | 63 | 18-01-31 |
De Liu
BRD | Director/Board Member | 51 | 15-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.84 | -1.18% | 35,131 |
24-04-24 | 0.85 | 0.00% | 48,037 |
24-04-23 | 0.85 | +1.19% | 35,542 |
24-04-22 | 0.84 | +0.72% | 34,438 |
24-04-19 | 0.834 | +0.97% | 33,809 |
Delayed Quote Nyse, April 25, 2024 at 04:10 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.85% | 51.88M | |
-2.80% | 380B | |
+22.71% | 1.98B | |
-18.71% | 1.08B | |
-11.48% | 831M | |
+5.94% | 792M | |
+58.57% | 789M | |
+43.52% | 671M | |
-31.60% | 349M | |
-10.50% | 291M |
- Stock Market
- Equities
- ZEPP Stock